Use of recombinant factor VIIa (NovoSeven®®) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux. - Luporsi, P.; Chopard, R.; Janin, S.; Racadot, E.; Bernard, Y.; Ecarnot, F.; Séronde, MF.; Briand, F.; Guignier, A.; Descotes-Genon, V.; Meneveau, N.; Schiele, F. (Acute Cardiac Care, 2011)